当前位置:Public Access >页面
Chinese/English
The efficacy and safety of Cadonilimab (AK-104) combined with FLOT regimen as an neoadjuvant therapy for locally advanced gastric/gastroesophageal junction adenocarcinoma: a prospective, multicenter, open phase II single arm clinical study
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
26 Man 2023-03-29

In hospital

chenshigong
25 Man 2023-02-01

In hospital

chenshigong
8 Man 2023-05-11

In hospital

chenshigong
38 Man 2023-12-15

In hospital

chenshigong
37 Man 2023-12-22

In hospital

chenshigong
36 Man 2023-09-15

In hospital

chenshigong
35 Woman 2023-09-09

In hospital

chenshigong
34 Man 2023-08-29

In hospital

chenshigong
33 Man 2023-10-04

In hospital

chenshigong
32 Man 2023-08-24

In hospital

chenshigong
31 Man 2023-08-29

In hospital

chenshigong
30 Man 2023-08-22

In hospital

chenshigong
29 Woman 2023-08-05

In hospital

chenshigong
28 Man 2023-07-21

In hospital

chenshigong
27 Man 2023-07-11

In hospital

chenshigong
24 Woman 2023-07-25

In hospital

chenshigong
23 Man 2023-08-01

In hospital

chenshigong
22 Woman 2023-07-25

In hospital

chenshigong
21 Man 2023-07-25

In hospital

chenshigong
20 Man 2023-07-18

In hospital

chenshigong
19 Man 2023-07-12

In hospital

chenshigong
18 Man 2023-07-02

In hospital

chenshigong
17 Man 2023-06-20

In hospital

chenshigong
16 Man 2023-06-07

In hospital

chenshigong
15 Man 2023-06-07

In hospital

chenshigong